Quantoom Biosciences is reinventing mRNA production by developing an RNA Platform (Nfinity™) that encompasses DNA (Nplify™) and RNA (Ntensify™) manufacturing and formulation (Ncapsulate™), along with critical reagent supply, from sequence to large-scale production. We are a team of scientists, engineers, and clinicians committed to solving some of the biggest DNA and RNA production challenges facing vaccines and therapeutics, by delivering greater access and autonomy to mRNA technology. Our facilities are strategically located in Belgium and France, in the heart of Europe, benefiting from an exceptional biotech ecosystem. Quantoom Biosciences is part of Univercells, a global life sciences Group with the mission of making biologics accessible to all.

Biotechnology

Life Sciences

Pharmaceutical

Quantoom Biosciences

Jose Castillo

Wendy Glasset

Jessica van Berlamont

Oladimeji F.

Oladimeji Fashola

Didier Masson

The Leadership Team at Quantoom Biosciences is responsible for setting the strategic vision, driving company growth, and ensuring operational excellence in the development of innovative mRNA production technologies. Comprised of the Chief Operating Officer, CEO, and dual Chief Technology Officers, this team oversees the integration of cutting-edge scientific advancements with efficient manufacturing processes to address key challenges in vaccine and therapeutic production, while navigating the biotech ecosystem in Europe.

Leadership Team

Operations

Business Development Team

Leadership Team

About

Team members

Other teams at Quantoom Biosciences

Operations

Business Development Team